Literature DB >> 31967337

The Risks or Lack Thereof of Migraine Treatments in Vascular Disease.

Hans-Christoph Diener1.   

Abstract

PREMISES: Patients with migraine have a co-morbidity with vascular diseases such as hypertension, coronary heart disease, and stroke. PROBLEM: This overview gives recommendations for the therapy of acute migraine attacks and for migraine  prevention in patients with vascular diseases. In particular, the use of triptans in patients with vascular diseases is discussed. POTENTIAL SOLUTIONS: Currently, there is a contraindication for the use of the triptans in patients with vascular disease, although there is no evidence that triptans increase the risk of heart attacks or stroke.
© 2020 American Headache Society.

Entities:  

Keywords:  coronary artery disease; hypertension; migraine; migraine prevention; stroke; treatment of migraine attack

Mesh：

Substances：

Year:  2020        PMID： 31967337     DOI： 10.1111/head.13749

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


  6 in total

Review 1.  Drug Safety in Episodic Migraine Management in Adults Part 1: Acute Treatments.

Authors:  Yulia Y Orlova; Sandhya Mehla; Abigail L Chua
Journal:  Curr Pain Headache Rep       Date:  2022-05-10

Review 2.  Headache as a Neurologic Manifestation of Systemic Disease.

Authors:  Alexandra N Cocores; Teshamae S Monteith
Journal:  Curr Treat Options Neurol       Date:  2022-03-18       Impact factor: 3.972

3.  Persistent headache after first-ever ischemic stroke: clinical characteristics and factors associated with its development.

Authors:  Elena R Lebedeva; Anton V Ushenin; Natalia M Gurary; Denis V Gilev; Nadezda V Kislyak; Jes Olesen
Journal:  J Headache Pain       Date:  2022-08-17       Impact factor: 8.588

4.  Efficacy and Safety of Lasmiditan as a Novel Acute Treatment in Chinese Patients with Migraine: A Subpopulation Analysis of the Randomized Controlled Phase 3 CENTURION Trial.

Authors:  Tingmin Yu; Li He; Xiaosu Yang; Jiying Zhou; Guogang Luo; Hebo Wang; Hongru Zhao; Quan Hu; Fei Ji; Shengyuan Yu
Journal:  Neurol Ther       Date:  2022-06-17

5.  Triptans and vascular comorbidity in persons over fifty: Findings from a nationwide insurance database - A cohort study.

Authors:  Karin Zebenholzer; Walter Gall; Andreas Gleiss; Antun R Pavelic; Christian Wöber
Journal:  Headache       Date:  2022-05       Impact factor: 5.311

Review 6.  Diagnosis and management of migraine in ten steps.

Authors:  Anna K Eigenbrodt; Håkan Ashina; Sabrina Khan; Hans-Christoph Diener; Dimos D Mitsikostas; Alexandra J Sinclair; Patricia Pozo-Rosich; Paolo Martelletti; Anne Ducros; Michel Lantéri-Minet; Mark Braschinsky; Margarita Sanchez Del Rio; Oved Daniel; Aynur Özge; Ayten Mammadbayli; Mihails Arons; Kirill Skorobogatykh; Vladimir Romanenko; Gisela M Terwindt; Koen Paemeleire; Simona Sacco; Uwe Reuter; Christian Lampl; Henrik W Schytz; Zaza Katsarava; Timothy J Steiner; Messoud Ashina
Journal:  Nat Rev Neurol       Date:  2021-06-18       Impact factor: 42.937
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.